ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors.

Javier Cortés et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.